Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Healthcare Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the... see more

Recent & Breaking News (TSX:RVX)

Resverlogix Reports Top-Line Results from ASSURE Clinical Trial

Canada NewsWire June 27, 2013

Resverlogix Reports Top-Line Results from ASSURE Clinical Trial

PR Newswire June 27, 2013

IIROC Trading Halt - RVX

Canada NewsWire June 27, 2013

Zenith Epigenetics Corp. commences operations

Canada NewsWire June 3, 2013

Zenith Epigenetics Corp. commences operations

PR Newswire June 3, 2013

Resverlogix Corp. announces completion of spin-out transaction

Canada NewsWire June 3, 2013

Resverlogix Corp. announces completion of spin-out transaction

PR Newswire June 3, 2013

Resverlogix Corp. shareholders approve plan of arrangement

Canada NewsWire May 28, 2013

Resverlogix Corp. shareholders approve plan of arrangement

PR Newswire May 28, 2013

Resverlogix Announces Details of Anticipated Distribution of Newco Shares

Canada NewsWire May 27, 2013

Resverlogix Announces Details of Anticipated Distribution of Newco Shares

PR Newswire May 27, 2013

Resverlogix's Board Approves Arrangement to Spin-Out RVX Therapeutics Inc. and Confirms Special Meeting of Shareholders

PR Newswire May 1, 2013

Resverlogix's Board Approves Arrangement to Spin-Out RVX Therapeutics Inc. and Confirms Special Meeting of Shareholders

Canada NewsWire May 1, 2013

Resverlogix Completes Dosing In ASSURE Clinical Trial

Canada NewsWire April 18, 2013

Resverlogix to Spin-out RVX Therapeutics Inc. to Shareholders

Canada NewsWire April 8, 2013

Resverlogix Secures Increase to Citibank Loan to $38.8 million

Canada NewsWire March 11, 2013

Resverlogix Secures Increase to Citibank Loan to $38.8 million

PR Newswire March 11, 2013

Resverlogix comments on steady climb of share price

Canada NewsWire January 31, 2013

Stockhouse @ the Bell: Stocks down on weak earnings

Stockhouse Editorial January 25, 2011

Junior mining stock pops on gold/copper grades

Sean Mason January 25, 2011